Covered recipient · General Payments record
KENNETH A KESLER
Allopathic & Osteopathic Physicians Thoracic Surgery (Cardiothoracic Vascular Surgery)
General Payments · PY2018–2024
$2,061.49
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $894.58 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DAVOL INC. | $161.86 | 1 |
| Ethicon US, LLC | $128.15 | 1 |
| ATRICURE, INC. | $105.58 | 2 |
| Zimmer Biomet Holdings, Inc. | $96.54 | 1 |
| Medtronic, Inc. | $92.54 | 1 |
| EISAI INC. | $84.52 | 3 |
| E.R. Squibb & Sons, L.L.C. | $84.18 | 1 |
| Merck Sharp & Dohme Corporation | $76.27 | 3 |
| Sumitomo Pharma America, Inc. | $24.10 | 1 |
| Kerecis Limited | $22.57 | 1 |
| Janssen Biotech, Inc. | $18.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ATRICURE, INC. | $84.34 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132896358 | CMS |
| ATRICURE, INC. | $21.24 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132887922 | CMS |
| Davol Inc. | $161.86 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127656452 | CMS |
| E.R. Squibb & Sons, L.L.C. | $84.18 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101412491 | CMS |
| Eisai Inc. | $34.50 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110758084 | CMS |
| Eisai Inc. | $21.40 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110758086 | CMS |
| Eisai Inc. | $28.62 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110758088 | CMS |
| Ethicon US, LLC | $128.15 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077631532 | CMS |
| Janssen Biotech, Inc. | $18.27 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078620862 | CMS |
| Kerecis Limited | $22.57 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120111297 | CMS |
| Medtronic, Inc. | $92.54 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119446123 | CMS |
| Merck Sharp & Dohme LLC | $20.55 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141568036 | CMS |
| Merck Sharp & Dohme LLC | $31.17 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141568038 | CMS |
| Merck Sharp & Dohme LLC | $24.55 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141825435 | CMS |
| Sumitomo Pharma America, Inc. | $24.10 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148873375 | CMS |
| Zimmer Biomet Holdings, Inc. | $96.54 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1155045803 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.